Native LDL induces interleukin-8 expression via H2O 2, p38 Kinase, and activator protein-1 in human aortic smooth muscle cells

Cardiovascular Research

Volumn 62, Issue 1, 2004, Pages 185-193

  Ryoo, Sung Woo ^a,b   Kim, Dong Uk ^a   Won, Misun ^a   Chung, Kyung Sook ^a   Jang, Young Joo ^a   Oh, Goo Taek ^a   Park, Song Kyu ^a   Maeng, Pil Jae ^b   Yoo, Hyang Sook ^a   Hoe, Kwang Lae ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Atherosclerosis; Interleukins; Lipoproteins; MAP kinase; Smooth muscle

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CATALASE; DACTINOMYCIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN; PROTEIN C FOS; PROTEIN C JUN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1;

AORTA; ARTICLE; ASSAY; CELL SPECIFICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LUCIFERASE REPORTER ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TIME; UPREGULATION;

AORTA; CAFFEIC ACIDS; CELLS, CULTURED; CORONARY VESSELS; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; HYDROGEN PEROXIDE; IMIDAZOLES; INTERLEUKIN-8; LIPOPROTEINS, LDL; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENYLETHYL ALCOHOL; PYRIDINES; SESQUITERPENES; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12144291010     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.01.002     Document Type: Article

References (39)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
2. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
3. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C.et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 398:1999;718-723.
4. Boisvert W.A., Santiago R., Curtiss L.K., Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101:1998;353-363.
5. Simonini A., Moscucci M., Muller D.W.et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation. 101:2000;1519-1526.
6. DeForge L.E., Preston A.M., Takeuchi E., Kenney J., Boxer L.A., Remick D.G. Regulation of interleukin 8 gene expression by oxidant stress. J. Biol. Chem. 268:1993;25568-25576.
7. Griendling K.K., Sorescu D., Lassegue B., Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20:2000;2175-2183.
8. Mukaida N., Mahe Y., Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 265:1990;21128-21133.
9. Yeh M., Leitinger N., de Martin R.et al. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21:2001;1585-1591.
10. Yu Y., Chadee K. Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J. Immunol. 161:1998;3746-3752.
11. Roebuck K.A. Regulation of interleukin-8 gene expression. J. Interferon Cytokine Res. 19:1999;429-438.
12. Kumar A., Knox A.J., Boriek A.M. CCAAT/enhancer-binding protein and activator protein-1 transcription factors regulate the expression of interleukin-8 through the mitogen-activated protein kinase pathways in response to mechanical stretch. J. Biol. Chem. 278:2003;18868-18876.
13. Steinberg D., Witztum J.L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 105:2002;2107-2111.
14. Terkeltaub R., Banka C.L., Solan J., Santoro D., Brand K., Curtiss L.K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14:1994;47-53.
15. Claise C., Edeas M., Chalas J.et al. Oxidized low-density lipoprotein induces the production of interleukin-8 by endothelial cells. FEBS Lett. 398:1996;223-227.
16. De Castellarnau C., Sanchez-Quesada J.L., Benitez S.et al. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20:2000;2281-2287.
17. Suriyaphol P., Fenske D., Zahringer U., Han S.R., Bhakdi S., Husmann M. Enzymatically modified nonoxidized low-density lipoprotein induces interleukin-8 in human endothelial cells: role of free fatty acids. Circulation. 106:2002;2581-2587.
18. Sachinidis A., Mengden T., Locher R., Brunner C., Vetter W. Novel cellular activities for low density lipoprotein in vascular smooth muscle cells. Hypertension. 15:1990;704-711.
19. Locher R., Brandes R.P., Vetter W., Barton M. Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases. Hypertension. 39:2002;645-650.
20. Ito T., Ikeda U., Yamamoto K., Shimada K. Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells. Atherosclerosis. 165:2002;51-55.
21. Jung Y.D., Fan F., McConkey D.J.et al. Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1beta-induced IL-8 expression in human vascular smooth muscle cells. Cytokine. 18:2002;206-213.
22. Metzler B., Li C., Hu Y., Sturm G., Ghaffari-Tabrizi N., Xu Q. LDL stimulates mitogen-activated protein kinase phosphatase-1 expression, independent of LDL receptors, in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;1862-1871.
23. Hoe K.L., Won M.S., Chung K.S.et al. Molecular cloning of gaf1, a Schizosaccharomyces pombe GATA factor, which can function as a transcriptional activator. Gene. 215:1998;319-328.
24. Barchowsky A., Soucy N.V., O'Hara K.A., Hwa J., Noreault T.L., Andrew A.S. A novel pathway for nickel-induced interleukin-8 expression. J. Biol. Chem. 277:2002;24225-24231.
25. Murakami R., Kambe F., Mitsuyama H.et al. Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23:2003;2034-2040.
26. Yasumoto K., Okamoto S., Mukaida N., Murakami S., Mai M., Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin-8 gene. J. Biol. Chem. 267:1992;22506-22511.
27. Mori N., Mukaida N., Ballard D.W., Matsushima K., Yamamoto N. Human T-cell leukemia virus type I Tax transactivates human interleukin-8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. Cancer Res. 58:1998;3993-4000.
28. Xu L., Xie K., Mukaida N., Matsushima K., Fidler I.J. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res. 59:1999;5822-5829.
29. Mazor R.L., Menendez I.Y., Ryan M.A., Fiedler M.A., Wong H.R. Sesquiterpene lactones are potent inhibitors of interleukin-8 gene expression in cultured human respiratory epithelium. Cytokine. 12:2000;239-245.
30. Sheehan M., Wong H.R., Hake P.W., Malhotra V., O'Connor M., Zingarelli B. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol. Pharmacol. 61:2002;953-963.
31. Vielma S.A., Krings G., Lopes-Virella M.F. Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB. Circ. Res. 92:2003;1130-1137.
32. Li D., Saldeen T., Romeo F., Mehta J.L. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation. 102:2000;1970-1976.
33. Rao G.N., Lassegue B., Griendling K.K., Alexander R.W. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene. 8:1993;2759-2764.
34. Rao G.N., Lassegue B., Griendling K.K., Alexander R.W., Berk B.C. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: role of protein kinase C. Nucleic Acids Res. 21:1993;1259-1263.
35. Griendling K.K., Harrison D.G. Dual role of reactive oxygen species in vascular growth. Circ. Res. 85:1999;562-563.
36. Chinetti G., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49:2000;497-505.
37. Ogata T., Miyauchi T., Sakai S., Irukayama-Tomobe Y., Goto K., Yamaguchi I. Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin. Sci. (Lond.). 103(Suppl. 48):2002;284S-288S.
38. Ahn J.D., Morishita R., Kaneda Y.et al. Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo. Circ. Res. 90:2002;1325-1332.
39. Rivard A., Principe N., Andres V. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis. Cardiovasc. Res. 45:2000;1026-1034.